New lung cancer pill hailed as 'off the charts' success - with patients surviving years longer than those on next best treatment

New Photo - New lung cancer pill hailed as 'off the charts' success - with patients surviving years longer than those on next best treatment
New lung cancer pill hailed as 'off the charts' success - with patients surviving years longer than those on next best treatment

Patients with incurable lung cancer could see their lives extended by several years by a drug hailed the 'best ever' treatment for the disease. Around six in ten patients given the daily tablet treated with lorlatinib survived for five years without their cancer progressing, compared to just eight per cent receiving standard care. Scientists said the results were 'off the charts' following a trial which found it improved survival rates by the longest time ever recorded.
More >> https://ift.tt/R891Git Full Article on Source: ANIO
#us #uk #world #fashion #showbiz #celebrity #lifestyle #top #news

No comments:

Powered by Blogger.